(Q79102815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Position of the American Dietetic Association: integration of medical nutrition therapy and pharmacotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Position of the American Dietetic Association: Integration of medical nutrition therapy and pharmacotherapy (English)

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

American Dietetic Association

16 March 2024

author

1

object named as

American Dietetic Association

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14520260

16 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

https://api.elsevier.com/content/article/PII:S0002822303012227?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

https://api.elsevier.com/content/article/PII:S0002822303012227?httpAccept=text/plain

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Journal of the American Dietetic Association

16 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1363-1370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

Position of The American Dietetic Association: cost-effectiveness of medical nutrition therapy

19 December 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Position of the American Dietetic Association: nutrition services in managed care

16 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Nutrition support teams: past, present, and future

16 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Disease management, registered dietitians and medical nutrition therapy

16 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Evidence-based disease management

16 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

An integral role of the dietitian: implications of the Diabetes Prevention Program

16 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Position of the American Dietetic Association: nutrition services in managed care

16 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

New Medicare changes to expand MNT access in 2002

16 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Are health plans changing their views on nutrition service coverage?

16 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

The prevention or delay of type 2 diabetes

16 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

The evidence for the effectiveness of medical nutrition therapy in diabetes management

16 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

16 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

16 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

16 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

16 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes

16 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Obesity as a disease: etiology, treatment, and management considerations for the obese patient

16 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Classification of obesity and assessment of obesity-related health risks

16 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Antipsychotic-induced weight gain

16 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

A cost constraint alone has adverse effects on food selection and nutrient density: an analysis of human diets by linear programming

16 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Can patient self-management help explain the SES health gradient?

16 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

5 a day fruit and vegetable intervention improves consumption in a low income population

16 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Choose a variety of fruits and vegetables daily: understanding the complexities.

16 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

16 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Report of the expert committee on the diagnosis and classification of diabetes mellitus

16 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

16 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Diabetes trends in the U.S.: 1990-1998.

16 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

16 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Economic costs of diabetes in the US in 2002.

16 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Dietary treatment and long-term weight loss and maintenance in type 2 diabetes

16 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

The continuing increase of diabetes in the US

16 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity

16 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Type 2 diabetes in children and adolescents. American Diabetes Association

16 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

16 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

16 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

American Diabetes Association

16 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

16 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

16 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

16 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate.

16 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Management of type 2 diabetes

16 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes

16 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition

16 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans

16 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

16 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Polycystic ovary syndrome

16 March 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control

16 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Intensive insulin therapy in critically ill patients

16 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

The obesity epidemic: pathophysiology and consequences of obesity

16 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Outpatient management of obesity: a primary care perspective

16 March 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Summary of the 2000 Surgeon General's listening session: toward a national action plan on overweight and obesity

16 March 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Biobehavioral influences on energy intake and adult weight gain

16 March 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Causes of adult weight gain

16 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

The role of physical activity in prevention and treatment of body weight gain in adults

16 March 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

16 March 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Increasing portion sizes in American diets: more calories, more obesity

16 March 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Foods commonly eaten in the United States, 1989-1991 and 1994-1996: are portion sizes changing?

16 March 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

16 March 2024

Obesity market overview

81

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

16 March 2024

Obesity

82

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options

16 March 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Thermogenic effects of sibutramine in humans

16 March 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

16 March 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Nonpharmacologic therapies that reduce blood pressure: a fresh perspective.

16 March 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Goal-oriented hypertension management: translating clinical trials to practice.

16 March 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Dietary Approaches to Stop Hypertension: a summary of study results. DASH Collaborative Research Group

16 March 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride

16 March 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Body weight, sodium intake and blood pressure

16 March 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia

16 March 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance

16 March 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial

16 March 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

Diet and drug therapy: a dynamic duo for reducing coronary heart disease risk

16 March 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.JADA.2003.08.016

16 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14520260%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference